https://p664637.webspaceconfig.de/izb-biotech-news/catalym-kuendigt-neue-finanzierung-in-hoehe-von-150-mio-an-um-ein-breit-angelegtes-phase-2b-entwicklungsprogramm-fuer-visugromab-zu-unterstuetzen/2026-07-15T14:14:57+02:00https://p664637.webspaceconfig.de/izb-biotech-news/pipeline-in-a-molecule-ein-innovativer-ansatz-mit-breitbandeffekt/2026-07-23T18:28:20+02:00https://p664637.webspaceconfig.de/izb-biotech-news/scirhom-sichert-sich-eine-63-mio-e-serie-a-finanzierung-zur-beschleunigten-entwicklung-von-irhom2-therapien-bei-autoimmunkrankheiten/2026-07-15T14:15:06+02:00https://p664637.webspaceconfig.de/izb-biotech-news/scirhom-erhaelt-genehmigung-des-ersten-antrags-fuer-eine-klinische-studie/2026-07-15T14:15:13+02:00https://p664637.webspaceconfig.de/izb-biotech-news/biom-laedt-zur-bayoconnect-forum-for-biotech-lifescience/2026-07-23T18:23:06+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosome-ernennt-dr-sabine-hauck-zur-chief-technology-officer/2026-07-15T14:15:18+02:00https://p664637.webspaceconfig.de/izb-biotech-news/neue-niedermolekulare-medikamente-der-zukunft-fuer-das-zns/2026-07-23T18:28:25+02:00https://p664637.webspaceconfig.de/izb-biotech-news/eisbach-erhaelt-45-mio-us-dollar-vom-cancer-focus-fund-zur-durchfuehrung-einer-phase-1-2-studie-mit-dem-fuehrenden-medikamentenkandidaten-eis-12656/2026-07-15T14:17:48+02:00https://p664637.webspaceconfig.de/izb-biotech-news/tag-der-offenen-tuer-am-biomedizinischen-centrum-der-lmu-am-16-maerz/2026-07-23T18:23:12+02:00https://p664637.webspaceconfig.de/izb-biotech-news/morphosys-schliesst-vereinbarung-zur-uebernahme-durch-pharmakonzern-novartis/2026-07-15T14:18:13+02:00https://p664637.webspaceconfig.de/izb-biotech-news/onkologie-experten-unterstuetzen-die-entwicklung-des-wirkstoffkandidaten-the001-von-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T15:19:18+02:00https://p664637.webspaceconfig.de/izb-biotech-news/peutinger-collegium-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:23:20+02:00https://p664637.webspaceconfig.de/izb-biotech-news/scirhom-reicht-antrag-fuer-erste-klinische-studien-am-menschen-mit-dem-wirkstoffkandidaten-sr-878-ein-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:32+02:00https://p664637.webspaceconfig.de/izb-biotech-news/goingpublic-feiert-ein-vierteljahrhundert-biotech-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:22+02:00https://p664637.webspaceconfig.de/izb-biotech-news/atriva-therapeutics-meldet-exklusive-absichtserklaerung-fuer-reverse-takeover-transaktion-mit-biocure-technology-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:15+02:00https://p664637.webspaceconfig.de/izb-biotech-news/hochkaraetiger-klinischer-beirat-fuer-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:23+02:00https://p664637.webspaceconfig.de/izb-biotech-news/gdf-15-neutralisieren-entwicklung-einer-neuen-klasse-von-immuntherapien-zur-krebsbekaempfung/2026-07-16T15:19:42+02:00https://p664637.webspaceconfig.de/izb-biotech-news/das-studierendenwerk-muenchen-oberbayern-besucht-das-izb/2026-07-16T15:19:32+02:00https://p664637.webspaceconfig.de/izb-biotech-news/23-studenten-aus-europa-besuchten-im-rahmen-des-amgen-scholar-program-das-izb/2026-08-12T14:49:16+02:00https://p664637.webspaceconfig.de/izb-biotech-news/vivoryon-therapeutics-verkuendet-fortschritte-des-lead-kandidaten-varoglutamstat-zur-behandlung-von-alzheimer-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:23:29+02:00https://p664637.webspaceconfig.de/izb-biotech-news/bayerische-biotechnologie-behauptet-sich-in-der-krise-und-waechst-weiter-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:23:31+02:00https://p664637.webspaceconfig.de/izb-biotech-news/leon-nanodrugs-begruesst-dr-hans-frickel-als-neuen-ceo-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:23:35+02:00https://p664637.webspaceconfig.de/izb-biotech-news/japanische-delegation-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:23:37+02:00https://p664637.webspaceconfig.de/izb-biotech-news/klifo-bringt-den-midsommar-ins-izb-izb-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:23:41+02:00https://p664637.webspaceconfig.de/izb-biotech-news/bicoll-praesentiert-auf-der-bio-international-convention/2026-07-23T18:23:46+02:00https://p664637.webspaceconfig.de/izb-biotech-news/offizielle-amtsuebergabe-auf-der-jahrestagung-der-max-planck-gesellschaft-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:23:52+02:00https://p664637.webspaceconfig.de/izb-biotech-news/secarna-ernennt-neuen-chief-business-officer-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:23:55+02:00https://p664637.webspaceconfig.de/izb-biotech-news/biotech-firma-origenis-begruesst-prof-hendrik-liebers-als-chairman-of-the-board-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:23:57+02:00https://p664637.webspaceconfig.de/izb-biotech-news/neue-praeklinische-daten-zeigen-dauerhafte-antitumoreffekte-von-secarna-pharmaceuticals-antisense-oligonukleotid-aso-therapien-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:28+02:00https://p664637.webspaceconfig.de/izb-biotech-news/chromotek-begruesst-rainer-gebhart-als-neuen-niederlassungsleiter-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:19+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosome-tritt-dem-imagio-konsortium-bei-um-die-entwicklung-von-krebstherapien-fuer-weichteilsarkome-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:24:00+02:00https://p664637.webspaceconfig.de/izb-biotech-news/suessstoffe-koennen-das-menschliche-immunsystem-beeinflussen-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:34+02:00https://p664637.webspaceconfig.de/izb-biotech-news/invitris-erhaelt-250-000-euro-fuer-vollstaendige-ausgruendung-aus-der-tum-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T15:20:33+02:00https://p664637.webspaceconfig.de/izb-biotech-news/eisbach-startet-klinische-phase-1-studie-mit-covid-19-virostatikum-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:20+02:00https://p664637.webspaceconfig.de/izb-biotech-news/izb-vernetzt-sich-mit-dem-shanghai-zhangjiang-hi-tech-park/2026-07-16T15:20:43+02:00https://p664637.webspaceconfig.de/izb-biotech-news/spezifische-verpackung-der-dna-beeinflusst-die-zellteilung-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T15:20:54+02:00https://p664637.webspaceconfig.de/izb-biotech-news/insempra-bringt-seinen-ersten-funktionalen-inhaltsstoff-fuer-konsumgueter-auf-den-markt-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:24+02:00https://p664637.webspaceconfig.de/izb-biotech-news/secarna-pharmaceuticals-und-scineuro-pharmaceuticals-schliessen-partnerschaft-zur-entwicklung-von-therapien-fuer-zns-erkrankungen/2026-07-15T17:22:52+02:00https://p664637.webspaceconfig.de/izb-biotech-news/adivo-zieht-in-neuen-hauptsitz-und-startet-erste-klinische-studie/2026-07-16T15:21:02+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosome-erhaelt-behoerdliche-genehmigung-fuer-erste-studie-am-menschen-mit-hauptprogramm-the001/2026-07-15T14:21:34+02:00https://p664637.webspaceconfig.de/izb-biotech-news/morphosys-beendet-eigene-praeklinische-forschungsprogramme-und-optimiert-weiter-kostenstruktur-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:28+02:00https://p664637.webspaceconfig.de/izb-biotech-news/insempra-ernennt-neuen-chief-operating-officer-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:25+02:00https://p664637.webspaceconfig.de/izb-biotech-news/us-unternehmen-neuron23-startet-klinische-phase-1-studie-zur-behandlung-von-parkinson-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:35+02:00https://p664637.webspaceconfig.de/izb-biotech-news/das-zebrafischgehirn-als-interaktive-karte-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:19+02:00https://p664637.webspaceconfig.de/izb-biotech-news/enno-spillner-wird-neuer-cfo-bei-formycon-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:21+02:00https://p664637.webspaceconfig.de/izb-biotech-news/ausbau-der-muenchner-wissenschaftslinie-hat-begonnen/2026-07-23T18:24:02+02:00https://p664637.webspaceconfig.de/izb-biotech-news/christian-pangratz-wird-neuer-ceo-von-atriva-therapeutics-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:18+02:00https://p664637.webspaceconfig.de/izb-biotech-news/leon-nanodrugs-schliesst-serie-d-finanzierung-ab/2026-07-15T14:14:37+02:00https://p664637.webspaceconfig.de/izb-biotech-news/9th-munich-life-science-pitch-day-im-izb-innovationen-treffen-investoren/2026-07-16T15:19:04+02:00https://p664637.webspaceconfig.de/izb-biotech-news/23-students-from-europe-visited-the-izb-as-part-of-the-amgen-scholar-program/2024-12-18T10:37:57+01:00https://p664637.webspaceconfig.de/izb-biotech-news/9-munich-life-science-pitch-day-at-the-izb-innovations-meet-investors/2026-07-23T18:24:15+02:00https://p664637.webspaceconfig.de/izb-biotech-news/adivo-expands-into-new-headquarters-as-first-clinical-study-begins/2026-07-15T14:30:57+02:00https://p664637.webspaceconfig.de/izb-biotech-news/atriva-therapeutics-announces-exclusive-letter-agreement-for-reverse-takeover-transaction-with-biocure-technology-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:40+02:00https://p664637.webspaceconfig.de/izb-biotech-news/expansion-of-the-munich-science-line-has-started-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:24:17+02:00https://p664637.webspaceconfig.de/izb-biotech-news/bavarian-biotechnology-maintains-its-position-in-the-crisis-and-continues-to-grow-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:24:19+02:00https://p664637.webspaceconfig.de/izb-biotech-news/bicoll-showcases-at-bio-international-convention/2026-07-23T18:24:21+02:00https://p664637.webspaceconfig.de/izb-biotech-news/biom-invites-to-bayoconnect-forum-for-biotech-lifescience/2026-07-23T18:24:24+02:00https://p664637.webspaceconfig.de/izb-biotech-news/biotech-company-origenis-welcomes-prof-hendrik-liebers-as-chairman-of-the-board/2026-07-23T18:24:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/catalym-announces-new-financing-of-150m-to-support-broad-phase-2b-development-program-for-visugromab/2026-07-15T14:25:57+02:00https://p664637.webspaceconfig.de/izb-biotech-news/christian-pangratz-becomes-new-ceo-of-atriva-therapeutics/2026-07-15T14:31:35+02:00https://p664637.webspaceconfig.de/izb-biotech-news/chromotek-welcomes-rainer-gebhart-as-new-site-manager-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:41+02:00https://p664637.webspaceconfig.de/izb-biotech-news/peutinger-collegium-visits-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:24:30+02:00https://p664637.webspaceconfig.de/izb-biotech-news/the-munich-bavaria-student-union-visits-the-izb/2026-07-23T18:24:33+02:00https://p664637.webspaceconfig.de/izb-biotech-news/the-zebrafish-brain-as-a-map-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:05:05+02:00https://p664637.webspaceconfig.de/izb-biotech-news/eisbach-receives-usd-4-5-million-investment-from-cancer-focus-fund-to-support-phase-1-2-trial-of-lead-candidate-eis-12656-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:42+02:00https://p664637.webspaceconfig.de/izb-biotech-news/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:43+02:00https://p664637.webspaceconfig.de/izb-biotech-news/enno-spillner-to-join-formycon-as-cfo-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:45+02:00https://p664637.webspaceconfig.de/izb-biotech-news/neutralizing-gdf-15-development-of-a-new-class-of-anti-cancer-immunotherapy/2026-07-16T16:06:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/goingpublic-celebrates-a-quarter-century-of-biotech-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T14:20:14+02:00https://p664637.webspaceconfig.de/izb-biotech-news/high-profile-clinical-advisory-board-for-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:46+02:00https://p664637.webspaceconfig.de/izb-biotech-news/insempra-launches-its-first-functional-component-for-consumer-goods-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:47+02:00https://p664637.webspaceconfig.de/izb-biotech-news/insempra-names-new-chief-operating-officer-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:48+02:00https://p664637.webspaceconfig.de/izb-biotech-news/invitris-receives-250000-eur-to-complete-spin-out-from-tum-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:49+02:00https://p664637.webspaceconfig.de/izb-biotech-news/izb-connects-with-shanghai-zhangjiang-hi-tech-park/2026-07-15T14:30:23+02:00https://p664637.webspaceconfig.de/izb-biotech-news/japanese-delegation-visits-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:24:35+02:00https://p664637.webspaceconfig.de/izb-biotech-news/klifo-brings-midsommar-to-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:24:41+02:00https://p664637.webspaceconfig.de/izb-biotech-news/leon-nanodrugs-welcomes-dr-hans-frickel-as-new-chief-executive-officer-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:24:45+02:00https://p664637.webspaceconfig.de/izb-biotech-news/leon-nanodrugs-secures-funds-in-a-series-d-financing/2026-07-15T14:25:42+02:00https://p664637.webspaceconfig.de/izb-biotech-news/morphosys-stops-proprietary-pre-clinical-research-programs-and-further-optimizes-cost-structure-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:54+02:00https://p664637.webspaceconfig.de/izb-biotech-news/morphosys-enters-into-business-combination-agreement-to-be-acquired-by-medicines-company-novartis/2026-07-15T14:27:40+02:00https://p664637.webspaceconfig.de/izb-biotech-news/novel-small-molecule-drugs-of-the-future-targeting-the-cns/2026-07-23T18:28:33+02:00https://p664637.webspaceconfig.de/izb-biotech-news/new-preclinical-data-show-long-term-antitumor-effects-of-secarna-pharmaceuticals-antisense-oligonucleotide-aso-therapies-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:56+02:00https://p664637.webspaceconfig.de/izb-biotech-news/official-handoff-ceremony-at-the-annual-meeting-of-the-max-planck-society-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:24:53+02:00https://p664637.webspaceconfig.de/izb-biotech-news/oncology-experts-to-support-the-development-of-thermosomes-clinical-candidate-the001-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:24:55+02:00https://p664637.webspaceconfig.de/izb-biotech-news/pipeline-in-a-molecule-an-innovative-application-with-a-broad-spectrum-effect/2026-07-23T18:28:23+02:00https://p664637.webspaceconfig.de/izb-biotech-news/scirhom-receives-approval-for-first-clinical-trial-application/2026-07-15T14:26:47+02:00https://p664637.webspaceconfig.de/izb-biotech-news/scirhom-submits-clinical-trial-application-for-first-in-human-trials-with-lead-candidate-sr-878-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:59+02:00https://p664637.webspaceconfig.de/izb-biotech-news/scirhom-secures-eur-63-million-series-a-financing-round-to-accelerate-irhom2-targeting-therapies-in-autoimmune-diseases/2026-07-15T14:26:38+02:00https://p664637.webspaceconfig.de/izb-biotech-news/secarna-appoints-new-chief-business-officer-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:25:04+02:00https://p664637.webspaceconfig.de/izb-biotech-news/secarna-pharmaceuticals-and-scineuro-pharmaceuticals-partner-to-develop-therapies-for-cns-diseases/2026-07-15T17:22:36+02:00https://p664637.webspaceconfig.de/izb-biotech-news/specific-packaging-of-dna-affects-cell-division-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:05:04+02:00https://p664637.webspaceconfig.de/izb-biotech-news/non-nutritive-sweeteners-may-affect-the-human-immune-system-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:04:57+02:00https://p664637.webspaceconfig.de/izb-biotech-news/open-day-at-the-lmu-biomedical-center-on-march-16/2026-07-23T18:25:08+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosomes-lead-program-the001-receives-regulatory-approval-for-first-in-human-trial/2026-07-15T14:31:04+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosome-appoints-dr-hauck-as-chief-technical-officer/2026-07-16T13:50:00+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosome-joins-imagio-consortium-to-advance-development-of-cancer-therapies-for-soft-tissue-sarcoma-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:25:10+02:00https://p664637.webspaceconfig.de/izb-biotech-news/us-based-neuron23-starts-phase-1-clinical-trial-in-parkinsons-disease-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:05:07+02:00https://p664637.webspaceconfig.de/izb-biotech-news/vivoryon-therapeutics-highlights-progress-of-lead-candidate-varoglutamstat-in-alzheimers-disease-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T18:25:13+02:00https://p664637.webspaceconfig.de/izb-biotech-news/amplifold-sichert-5-mio-euro-fuer-ultrasensitive-dna-origami-lateral-flow-diagnostik/2026-07-22T10:38:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/twogee-biotech-erhaelt-216-mio-e-seed-finanzierung-fuer-enzymplattform/2026-07-22T10:45:24+02:00https://p664637.webspaceconfig.de/izb-biotech-news/twogee-biotech-raises-e2-16m-seed-round-for-enzyme-platform/2026-07-22T10:46:32+02:00https://p664637.webspaceconfig.de/izb-biotech-news/t-curx-staerkt-in-vivo-car-t-plattform-durch-uebernahme-von-pantherna-therapeutics-und-erhaelt-phase-1-zulassung-fuer-tcx-001/2026-07-23T16:48:15+02:00https://p664637.webspaceconfig.de/izb-biotech-news/t-curx-strengthens-in-vivo-car-t-platform-with-pantherna-acquisition-and-achieves-phase-1-approval-for-tcx-001/2026-07-23T16:48:22+02:00https://p664637.webspaceconfig.de/izb-biotech-news/amplifold-raises-e5m-to-advance-dna-origami-ultrasensitive-lateral-flow-diagnostics/2026-07-22T10:38:58+02:00https://p664637.webspaceconfig.de/izb-biotech-news/gilead-uebernimmt-tubulis-im-rahmen-einer-5-milliarden-dollar-expansion-im-bereich-adc-onkologie/2026-07-22T09:32:21+02:00https://p664637.webspaceconfig.de/izb-biotech-news/gilead-to-acquire-tubulis-in-5b-adc-oncology-expansion-2/2026-07-22T09:56:59+02:00https://p664637.webspaceconfig.de/izb-biotech-news/twogee-biotech-mit-enzymen-biomasseabfaelle-in-nachhaltige-2g-rohstoffe-verwandeln/2026-07-30T20:52:04+02:00https://p664637.webspaceconfig.de/izb-biotech-news/twogee-biotech-turning-biomass-waste-into-sustainable-2g-raw-materials-with-enzymes/2026-07-30T20:52:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/t-curx-sichert-sich-20-mio-us-dollar-in-series-a-finanzierung-zur-weiterentwicklung-einer-nicht-viralen-car-t-plattform/2026-07-22T10:39:28+02:00https://p664637.webspaceconfig.de/izb-biotech-news/t-curx-secures-20m-series-a-to-advance-non-viral-car-t-platform/2026-07-22T10:39:54+02:00https://p664637.webspaceconfig.de/izb-biotech-news/tubulis-sichert-sich-344-millionen-euro-in-series-c-finanzierung-zur-weiterentwicklung-seiner-adc-pipeline/2026-07-22T10:22:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/tubulis-secures-e344m-series-c-to-advance-adc-pipeline/2026-07-22T10:38:16+02:00https://p664637.webspaceconfig.de/izb-biotech-news/catalym-behandelt-ersten-patienten-in-phase-2b-studie-zur-bewertung-von-visugromab-in-kombination-mit-chemoimmuntherapie-bei-nicht-plattenepithelialem-nsclc/2026-07-22T10:18:58+02:00https://p664637.webspaceconfig.de/izb-biotech-news/catalym-doses-first-patient-in-phase-2b-trial-evaluating-visugromab-in-combination-with-chemoimmunotherapy-in-non-squamous-nsclc-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-22T10:26:19+02:00https://p664637.webspaceconfig.de/izb-biotech-news/ibidi-mit-staatspreis-bayerns-best-50-ausgezeichnet/2026-07-22T10:22:30+02:00https://p664637.webspaceconfig.de/izb-biotech-news/ibidi-receives-bavarias-best-50-state-award-for-strong-growth/2026-07-22T10:21:58+02:00https://p664637.webspaceconfig.de/izb-biotech-news/leon-nanodrugs-verstaerkt-fuehrungsteam-mit-neuem-ceo/2026-07-09T12:07:15+02:00https://p664637.webspaceconfig.de/izb-biotech-news/leon-nanodrugs-strengthens-leadership-team-with-new-ceo/2026-07-09T12:08:26+02:00https://p664637.webspaceconfig.de/izb-biotech-news/tubulis-praesentiert-neue-praeklinische-daten-fuer-die-fuehrenden-adc-kandidaten-gegen-solide-tumore-auf-der-aacr-jahrestagung-2024-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-09T12:07:15+02:00https://p664637.webspaceconfig.de/izb-biotech-news/tubulis-presents-novel-preclinical-data-for-lead-adc-candidates-targeting-solid-tumors-at-aacr-2024-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-09T12:08:25+02:00https://p664637.webspaceconfig.de/izb-biotech-news/tubulis-sichert-sich-bedeutende-serie-b2-finanzierung-in-hoehe-von-128-mio-euro-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-22T12:21:08+02:00https://p664637.webspaceconfig.de/izb-biotech-news/tubulis-secures-significant-eur-128-million-series-b2-financing-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-22T14:55:04+02:00https://p664637.webspaceconfig.de/izb-biotech-news/catalym-staerkt-board-of-directors-und-wissenschaftlichen-beirat-mit-renommierten-branchenexperten-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-09T12:07:15+02:00https://p664637.webspaceconfig.de/izb-biotech-news/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-09T12:08:25+02:00https://p664637.webspaceconfig.de/izb-biotech-news/prof-corinna-dawid-leitet-das-leibniz-lsbtum/2026-07-15T13:24:02+02:00https://p664637.webspaceconfig.de/izb-biotech-news/prof-corinna-dawid-leads-leibniz-lsbtum-into-the-future/2026-07-15T13:24:46+02:00https://p664637.webspaceconfig.de/izb-biotech-news/30-jahre-izb-jubilaeum-eines-biotech-pioniers-izb-martinsried/2026-07-22T17:11:18+02:00https://p664637.webspaceconfig.de/izb-biotech-news/30-years-izb-anniversary-of-a-biotech-pioneer-izb-martinsried/2026-07-22T17:12:53+02:00https://p664637.webspaceconfig.de/izb-biotech-news/grosse-buehne-dpa-berichtet-ueber-izb-strat-ups/2026-07-22T17:13:31+02:00https://p664637.webspaceconfig.de/izb-biotech-news/in-the-spotlight-dpa-features-izb-start-ups/2026-07-22T17:14:09+02:00https://p664637.webspaceconfig.de/izb-biotech-news/protevo-bio-uebernimmt-plattformtechnologien-zur-skalierbaren-proteinproduktion/2026-07-22T10:54:11+02:00https://p664637.webspaceconfig.de/izb-biotech-news/protevo-bio-acquires-platform-technologies-for-scalable-protein-production/2026-07-22T11:42:12+02:00https://p664637.webspaceconfig.de/izb-biotech-news/ein-abend-fuer-neue-netzwerke-wirtschaftsempfang-2025-im-izb/2026-07-15T13:24:02+02:00https://p664637.webspaceconfig.de/izb-biotech-news/an-evening-for-new-connections-business-reception-at-the-izb/2026-07-22T16:07:26+02:00https://p664637.webspaceconfig.de/izb-biotech-news/30-jahre-izb-deutschlands-globaler-hotspot-fuer-biotechnologie-ein-gespraech-mit-christian-gnam/2026-07-22T11:42:17+02:00https://p664637.webspaceconfig.de/izb-biotech-news/30-years-of-izb-inside-germanys-global-biotech-village-with-christian-gnam/2026-07-22T11:42:22+02:00https://p664637.webspaceconfig.de/izb-biotech-news/aatec-medical-erhaelt-4-millionen-euro-fuer-klinische-studien-zu-atemwegstherapien/2026-07-22T11:42:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/aatec-medical-raises-eur-4-million-for-respiratory-drug-trials/2026-07-22T11:42:31+02:00https://p664637.webspaceconfig.de/izb-biotech-news/momentum-biotechnologies-uebernimmt-omicscouts-und-erweitert-seine-proteomik-kompetenzen/2026-07-16T15:11:46+02:00https://p664637.webspaceconfig.de/izb-biotech-news/momentum-biotechnologies-acquires-omicscouts-expanding-proteomics-capabilities/2026-07-16T15:12:04+02:00https://p664637.webspaceconfig.de/izb-biotech-news/invitris-fuer-den-eic-accelerator-ausgewaehlt-eine-revolution-in-der-personalisierten-medizin/2026-07-16T15:11:48+02:00https://p664637.webspaceconfig.de/izb-biotech-news/invitris-selected-for-eic-accelerator-revolutionizing-personalized-medicine/2026-07-16T15:12:07+02:00https://p664637.webspaceconfig.de/izb-biotech-news/closing-the-gap-weibliche-fuehrungskraefte-in-der-biotech-branche/2026-07-16T15:11:52+02:00https://p664637.webspaceconfig.de/izb-biotech-news/closing-the-gap-female-leadership-in-biotech/2026-07-16T15:12:09+02:00https://p664637.webspaceconfig.de/izb-biotech-news/biotechnologie-staerken-politischer-austausch-am-izb-zur-zukunft-des-innovationsstandorts-deutschland/2026-07-16T15:11:57+02:00https://p664637.webspaceconfig.de/izb-biotech-news/strengthening-biotechnology-political-dialogue-at-izb-on-germanys-innovation-future/2026-07-16T15:12:11+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosomes-fuehrender-wirkstoffkandidat-the001-zeigt-vielversprechende-erste-klinische-daten-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:25:00+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosomes-lead-compound-the001-shows-promising-initial-clinical-data-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:24:38+02:00https://p664637.webspaceconfig.de/izb-biotech-news/matthias-mann-und-wolfgang-baumeister-gewinnen-gairdner-international-awards-2026/2026-07-16T15:11:45+02:00https://p664637.webspaceconfig.de/izb-biotech-news/matthias-mann-and-wolfgang-baumeister-win-gairdner-international-awards-2026/2026-07-16T15:12:01+02:00https://p664637.webspaceconfig.de/izb-biotech-news/zwei-auszeichnungen-fuer-max-planck-forscher-elena-conti-und-wolfgang-baumeister/2026-07-22T16:40:45+02:00https://p664637.webspaceconfig.de/izb-biotech-news/max-planck-scientists-elena-conti-and-wolfgang-baumeister-receive-prestigious-awards/2026-07-22T16:40:52+02:00https://p664637.webspaceconfig.de/izb-biotech-news/catalyms-visugromab-durchbruch-bei-aufhebung-von-checkpoint-inhibitor-resistenz-in-nature-veroeffentlicht/2026-07-22T12:21:03+02:00https://p664637.webspaceconfig.de/izb-biotech-news/catalyms-visugromab-breakthrough-in-reversing-cancer-resistance-published-in-nature/2026-07-22T12:20:55+02:00https://p664637.webspaceconfig.de/izb-biotech-news/eisbach-bio-erhaelt-cprit-foerderung-fuer-die-klinische-entwicklung-eines-neuen-krebstherapeutikums/2026-07-16T15:11:58+02:00https://p664637.webspaceconfig.de/izb-biotech-news/eisbach-bio-secures-cprit-grant-to-advance-novel-cancer-therapeutic/2026-07-16T15:12:12+02:00https://p664637.webspaceconfig.de/izb-biotech-news/drei-izb-start-ups-gewinnen-european-lifestars-awards-2024-in-london/2026-07-22T16:58:54+02:00https://p664637.webspaceconfig.de/izb-biotech-news/three-izb-start-ups-win-european-lifestars-award-2024-in-london/2026-07-22T16:59:03+02:00https://p664637.webspaceconfig.de/izb-biotech-news/scirhom-kuendigt-die-erste-dosierung-fuer-das-fuehrende-programm-sr-878-an/2026-07-15T13:24:59+02:00https://p664637.webspaceconfig.de/izb-biotech-news/scirhom-announces-first-dosing-in-first-in-man-trial-for-lead-program-sr-878/2026-07-15T13:24:38+02:00https://p664637.webspaceconfig.de/izb-biotech-news/eisbach-bio-gibt-die-dosierung-der-ersten-patientin-in-der-phase-1-2-studie-fuer-eis-12656-bekannt/2026-07-15T13:24:59+02:00https://p664637.webspaceconfig.de/izb-biotech-news/eisbach-bio-announces-first-patient-dosed/2026-07-15T13:24:38+02:00https://p664637.webspaceconfig.de/izb-biotech-news/eisbach-fda-genehmigt-ind-antrag-fuer-fuehrenden-medikamentenkandidaten-eis-12656-einen-erstklassigen-allosterische-inhibitor-von-alc1-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:21:11+02:00https://p664637.webspaceconfig.de/izb-biotech-news/eisbach-receives-ind-clearance-for-lead-candidate-eis-12656-a-first-in-class-allosteric-inhibitor-of-alc1-from-the-fda-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:21:24+02:00https://p664637.webspaceconfig.de/izb-biotech-news/insempra-schliesst-20-millionen-us-dollar-finanzierung-ab-um-die-entwicklung-von-natuerlichen-inhaltsstoffen-der-naechsten-generation-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie/2026-07-15T13:21:12+02:00https://p664637.webspaceconfig.de/izb-biotech-news/insempra-completes-20-million-financing-to-advance-the-development-of-next-generation-bio-based-ingredients-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:21:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosome-erreicht-naechste-dosisstufe-in-phase-i-studie-mit-wirkstoffkandidaten-the001-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:21:14+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosome-advances-phase-i-trial-with-lead-candidate-to-next-dose-level-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:21:29+02:00https://p664637.webspaceconfig.de/izb-biotech-news/tubulis-lizenziert-ind-fertiges-adc-fuer-die-behandlung-von-lymphomen-an-oncoteq-aus-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:21:15+02:00https://p664637.webspaceconfig.de/izb-biotech-news/tubulis-out-licenses-ind-ready-adc-for-the-treatment-of-lymphoma-to-oncoteq-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:21:37+02:00https://p664637.webspaceconfig.de/izb-biotech-news/morphosys-beendet-das-jahr-mit-positiven-phase-3-daten-und-erfolgreicher-barkapitalerhoehung-von-rund-1027-millionen-euro-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-22T13:28:25+02:00https://p664637.webspaceconfig.de/izb-biotech-news/morphosys-ends-the-year-with-positive-phase-3-data-and-successful-cash-capital-increase-of-approximately-eur-102-7-million-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-22T13:28:30+02:00https://p664637.webspaceconfig.de/izb-biotech-news/m1-munich-medicine-alliance-weichenstellung-um-deutschlands-medizinstandort-nr-1-zu-werden-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T16:47:55+02:00https://p664637.webspaceconfig.de/izb-biotech-news/m1-munich-medical-alliance-becoming-germanys-no-1-medical-location-innovations-und-grunderzentrum-biotechnologie-izb/2026-07-16T13:49:41+02:00https://p664637.webspaceconfig.de/izb-biotech-news/durchbruch-in-der-fluoreszenzmikroskopie-am-max-planck-institut-fuer-biochemie-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T12:10:26+02:00https://p664637.webspaceconfig.de/izb-biotech-news/breakthrough-in-fluorescence-microscopy-at-the-max-planck-institute-of-biochemistry-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T12:10:38+02:00https://p664637.webspaceconfig.de/izb-biotech-news/wirtschaftsempfang-2023-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:05:16+02:00https://p664637.webspaceconfig.de/izb-biotech-news/business-reception-2023-innovation-and-founder-center-biotechnology-izb/2026-07-22T14:51:00+02:00https://p664637.webspaceconfig.de/izb-biotech-news/biotech-report-der-vfa-biopharmazeutika-steigern-erfolgreich-marktanteil-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:24:59+02:00https://p664637.webspaceconfig.de/izb-biotech-news/biotech-report-by-vfa-biopharmaceuticals-successfully-gain-market-share-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:24:37+02:00https://p664637.webspaceconfig.de/izb-biotech-news/praeklinische-wirksamkeits-und-sicherheitsdaten-fuer-vigenerons-innovativen-ansatz-zur-behandlung-von-retinitis-pigmentosa-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-22T14:06:56+02:00https://p664637.webspaceconfig.de/izb-biotech-news/preclinical-efficacy-and-safety-data-for-vigenerons-innovative-approach-to-the-treatment-of-retinitis-pigmentosa-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-22T14:56:55+02:00https://p664637.webspaceconfig.de/izb-biotech-news/max-planck-institut-fuer-biochemie-veroeffentlichung-in-nature-ueber-die-dunkle-materie-der-proteomik-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T12:10:59+02:00https://p664637.webspaceconfig.de/izb-biotech-news/max-planck-institute-of-biochemistry-nature-publication-addressing-the-dark-matter-of-proteomics-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T12:11:37+02:00https://p664637.webspaceconfig.de/izb-biotech-news/zurueck-mit-spannenden-themen-und-multimedialer-zaubershow-der-jahresempfang-des-lmu-klinikums-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T14:45:00+02:00https://p664637.webspaceconfig.de/izb-biotech-news/lmu-hospitals-annual-reception-returned-this-year-with-exciting-topics-and-a-multimedia-magic-show-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-23T14:45:17+02:00https://p664637.webspaceconfig.de/izb-biotech-news/bau-des-neuen-hauner-am-campus-grosshadern-hat-begonnen-innovations-und-gruenderzentrum-biotechnologie-izb/2026-08-12T15:07:14+02:00https://p664637.webspaceconfig.de/izb-biotech-news/construction-of-the-new-hauner-at-the-grosshadern-campus-has-started-innovations-und-gruenderzentrum-biotechnologie-izb/2026-08-12T15:13:51+02:00https://p664637.webspaceconfig.de/izb-biotech-news/4sc-erhaelt-von-der-ema-den-orphan-drug-designation-fuer-resminostat-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:23:22+02:00https://p664637.webspaceconfig.de/izb-biotech-news/4scs-resminostat-receives-orphan-drug-designation-from-the-european-medicines-agency-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:24:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/morphosys-wirkstoff-tulmimetostat-erhaelt-fast-track-status-der-fda-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:23:21+02:00https://p664637.webspaceconfig.de/izb-biotech-news/morphosys-program-tulmimetostat-receives-fda-fast-track-designation-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:24:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/adivo-wird-teil-des-weltweit-fuehrenden-unternehmens-fuer-tiergesundheit-zoetis-alumnus-des-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:23:20+02:00https://p664637.webspaceconfig.de/izb-biotech-news/adivo-becomes-part-of-the-worlds-leading-animal-health-company-zoetis-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:24:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/amsilk-erweitert-serie-c-finanzierung-auf-54-mio-euro-unterstuetzt-von-namhaften-investoren-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:05:13+02:00https://p664637.webspaceconfig.de/izb-biotech-news/amsilk-extends-series-c-financing-to-eur-54-million-backed-by-renowned-investors-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:24:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/erc-advanced-grant-in-hoehe-von-knapp-21-mio-euro-fuer-max-planck-direktorin-prof-dr-brenda-schulman-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:23:19+02:00https://p664637.webspaceconfig.de/izb-biotech-news/erc-advanced-grant-of-nearly-2-1-million-euros-for-max-planck-director-professor-dr-brenda-schulman-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:24:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/vivoryon-therapeutics-gibt-update-zur-klinischen-entwicklung-seines-lead-kandidaten-gegen-alzheimer/2026-07-15T13:23:18+02:00https://p664637.webspaceconfig.de/izb-biotech-news/vivoryon-therapeutics-gives-update-on-clinical-development-of-its-lead-candidate-against-alzheimers-disease/2026-07-15T13:24:27+02:00https://p664637.webspaceconfig.de/izb-biotech-news/fortbildungsveranstaltungen-fuer-projektleiter-und-beauftragte-fuer-biologische-sicherheit/2026-07-15T14:21:38+02:00https://p664637.webspaceconfig.de/izb-biotech-news/training-events-for-project-managers-and-biological-safety-officers/2026-07-15T14:31:10+02:00https://p664637.webspaceconfig.de/izb-biotech-news/was-das-immunsystem-anfaellig-fuer-toedliche-infektionen-macht/2026-07-16T13:05:16+02:00https://p664637.webspaceconfig.de/izb-biotech-news/when-life-begins-too-early/2026-07-16T13:05:26+02:00https://p664637.webspaceconfig.de/izb-biotech-news/image-video-izb-2025/2026-07-16T13:49:24+02:00https://p664637.webspaceconfig.de/izb-biotech-news/25699/2026-07-22T16:28:15+02:00https://p664637.webspaceconfig.de/izb-biotech-news/das-izb-zieht-globale-biotech-partner-an/2026-07-23T14:57:59+02:00https://p664637.webspaceconfig.de/izb-biotech-news/izb-attracts-global-biotech-partners/2026-07-23T14:58:13+02:00https://p664637.webspaceconfig.de/izb-biotech-news/wir-moechten-das-therapeutische-potenzial-von-aat-fuer-patienten-mit-entzuendlichen-lungenerkrankungen-erschliessen/2026-08-12T16:04:24+02:00https://p664637.webspaceconfig.de/izb-biotech-news/we-want-to-unlock-the-therapeutic-potential-of-aat-for-patients-with-inflammatory-lung-diseases/2026-08-12T16:04:46+02:00https://p664637.webspaceconfig.de/izb-biotech-news/christian-gnam-folgt-dr-peter-zobel-und-wird-neuer-geschaeftsfuehrer-des-innovations-und-gruenderzentrums-biotechnologie-izb/2026-07-22T14:54:01+02:00https://p664637.webspaceconfig.de/izb-biotech-news/christian-gnam-succeeds-dr-peter-zobel-as-new-managing-director-of-the-biotechnology-innovation-and-start-up-center-izb/2026-07-22T14:54:09+02:00https://p664637.webspaceconfig.de/izb-biotech-news/ein-einzigartiger-ansatz-fuer-die-biopharmazeutische-formulierungsentwicklung/2026-07-15T13:23:14+02:00https://p664637.webspaceconfig.de/izb-biotech-news/a-unique-approach-to-biopharmaceutical-formulation-development/2026-07-15T13:24:26+02:00https://p664637.webspaceconfig.de/izb-biotech-news/izb-biotech-news-neuer-hightech-ansatz-zur-fruehzeitigen-erkennung-kranker-zellen-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:23:13+02:00https://p664637.webspaceconfig.de/izb-biotech-news/new-high-tech-approach-to-detect-diseased-cells-at-an-early-stage-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-22T14:18:11+02:00https://p664637.webspaceconfig.de/izb-biotech-news/adivos-erstes-onkologie-programm-erhaelt-eingeschraenkte-marktzulassung-von-der-ema-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-16T13:05:09+02:00https://p664637.webspaceconfig.de/izb-biotech-news/adivos-erstes-onkologie-programm-erhaelt-eingeschraenkte-marktzulassung-von-der-ema/2026-07-16T13:05:24+02:00https://p664637.webspaceconfig.de/izb-biotech-news/leibniz-institut-in-freising-identifiziert-neue-biomarker-fuer-den-kaffeekonsum-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:23:13+02:00https://p664637.webspaceconfig.de/izb-biotech-news/leibniz-institute-in-freising-identifies-new-biomarkers-for-coffee-consumption-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:24:26+02:00https://p664637.webspaceconfig.de/izb-biotech-news/morphosys-schliesst-exklusive-globale-lizenzvereinbarung-mit-novartis-fuer-praeklinisches-onkologie-programm-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:23:12+02:00https://p664637.webspaceconfig.de/izb-biotech-news/morphosys-signs-exclusive-global-license-agreement-with-novartis-for-preclinical-oncology-program-innovations-und-grunderzentrum-biotechnologie-izb/2026-07-15T13:24:26+02:00https://p664637.webspaceconfig.de/izb-biotech-news/weihnachtsgruesse-aus-dem-izb-2022/2026-07-15T13:23:11+02:00https://p664637.webspaceconfig.de/izb-biotech-news/weihnachtsgruesse-aus-dem-izb-2022/2026-07-15T13:24:25+02:00https://p664637.webspaceconfig.de/izb-biotech-news/netzwerktreffen-mit-den-partnern-der-plattform-life-sciences-im-izb/2026-07-15T13:23:11+02:00https://p664637.webspaceconfig.de/izb-biotech-news/netzwerktreffen-mit-den-partnern-der-plattform-life-sciences-im-izb/2026-07-15T13:24:25+02:00https://p664637.webspaceconfig.de/izb-biotech-news/immunic-praesentierte-in-einem-fe-webcast-zu-multipler-sklerose-neue-daten-zu-ihrem-hauptprodukt-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T13:40:49+02:00https://p664637.webspaceconfig.de/izb-biotech-news/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-22T13:27:19+02:00https://p664637.webspaceconfig.de/izb-biotech-news/catalym-schliesst-ueberzeichnete-serie-c-finanzierung-ueber-50-mio-euro-ab-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T14:22:49+02:00https://p664637.webspaceconfig.de/izb-biotech-news/catalym-raises-eur-50-million-in-oversubscribed-series-c-financing-innovations-und-gruenderzentrum-biotechnologie-izb/2026-07-15T14:31:56+02:00https://p664637.webspaceconfig.de/izb-biotech-news/veredelte-molekuele-die-die-welt-veraendern/2026-08-12T16:18:08+02:00https://p664637.webspaceconfig.de/izb-biotech-news/modified-molecules-that-are-changing-the-world/2026-08-12T16:18:31+02:00https://p664637.webspaceconfig.de/izb-biotech-news/amsilk-zieht-vom-izb-in-groessere-raeumlichkeiten-um-und-plant-den-ausbau-der-produktion-von-nachhaltigen-materialloesungen/2026-08-12T15:37:08+02:00https://p664637.webspaceconfig.de/izb-biotech-news/amsilk-relocates-from-izb-to-larger-premises-with-plans-to-scale-up-its-production-of-sustainable-material-solutions/2026-08-12T15:42:43+02:00https://p664637.webspaceconfig.de/izb-biotech-news/immunic-sichert-sich-60-mio-usd-pipe-finanzierung/2026-07-15T13:47:50+02:00https://p664637.webspaceconfig.de/izb-biotech-news/immunic-secures-usd-60-million-pipe-financing/2026-07-16T13:50:53+02:00https://p664637.webspaceconfig.de/izb-biotech-news/rna-technologie-koennte-gegen-knochenschwund-helfen/2026-07-15T16:48:17+02:00https://p664637.webspaceconfig.de/izb-biotech-news/rna-technology-could-help-fight-bone-loss/2026-07-16T13:52:00+02:00https://p664637.webspaceconfig.de/izb-biotech-news/nachwuchswissenschaftlerinnen-vom-max-planck-institut-fuer-biologische-intelligenz-mit-young-scientist-award-ausgezeichnet/2026-07-15T17:11:53+02:00https://p664637.webspaceconfig.de/izb-biotech-news/junior-female-scientists-from-the-max-planck-institute-for-biological-intelligence-honored-with-young-scientist-award/2026-07-16T13:51:17+02:00https://p664637.webspaceconfig.de/izb-biotech-news/insempra-beruft-zwei-neue-mitglieder-in-seinen-wissenschaftlichen-beirat/2026-07-15T13:56:53+02:00https://p664637.webspaceconfig.de/izb-biotech-news/insempra-appoints-two-new-members-to-its-scientific-advisory-board/2026-07-16T13:50:58+02:00https://p664637.webspaceconfig.de/izb-biotech-news/adivo-erhaelt-25-mio-euro-eu-foerderung/2026-07-15T13:58:09+02:00https://p664637.webspaceconfig.de/izb-biotech-news/adivo-receives-euro-25-million-eu-grant/2026-07-16T13:50:09+02:00https://p664637.webspaceconfig.de/izb-biotech-news/550-jahre-lmu-medizin/2026-07-15T13:58:58+02:00https://p664637.webspaceconfig.de/izb-biotech-news/550-years-of-lmu-medicine/2026-07-15T13:59:09+02:00https://p664637.webspaceconfig.de/izb-biotech-news/prof-dr-petra-schwille-direktorin-am-max-planck-institut-fuer-biochemie-in-martinsried-mit-otto-warburg-medaille-ausgezeichnet/2026-07-15T13:59:56+02:00https://p664637.webspaceconfig.de/izb-biotech-news/professor-petra-schwille-director-at-the-max-planck-institute-of-biochemistry-in-martinsried-awarded-with-otto-warburg-medal/2026-07-15T14:00:17+02:00https://p664637.webspaceconfig.de/izb-biotech-news/ein-nukleinsaeurechemie-cluster-soll-deutschlands-fe-zukunft-gestalten/2026-07-29T16:58:33+02:00https://p664637.webspaceconfig.de/izb-biotech-news/a-nucleic-acid-chemistry-cluster-to-shape-germanys-rd-future/2026-07-29T17:00:04+02:00https://p664637.webspaceconfig.de/izb-biotech-news/sirion-biotech-auf-expansionskurs-fuer-die-zell-und-gentherapie/2026-07-16T17:53:36+02:00https://p664637.webspaceconfig.de/izb-biotech-news/sirion-biotech-on-expansion-course-for-cell-and-gene-therapy/2026-07-16T17:55:44+02:00https://p664637.webspaceconfig.de/izb-biotech-news/campus-hotel-restaurants-und-faculty-club-wieder-geoeffnet/2026-07-15T14:47:39+02:00https://p664637.webspaceconfig.de/izb-biotech-news/campus-hotel-restaurants-und-faculty-club-wieder-geoeffnet/2026-07-16T17:30:06+02:00https://p664637.webspaceconfig.de/izb-biotech-news/crashkurs-biotechnologie-wissen-fuer-nicht-biologen/2026-07-22T13:28:08+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosome-reports-positive-phase-i-results-for-the001-in-advanced-soft-tissue-sarcomas/2026-07-29T17:01:11+02:00https://p664637.webspaceconfig.de/izb-biotech-news/thermosome-initiates-final-dose-level-in-phase-i-trial/2026-07-29T17:03:37+02:00https://p664637.webspaceconfig.de/izb-biotech-news/gilead-and-tubulis-enter-into-exclusive-option-and-license-agreement/2026-07-22T12:20:47+02:00